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Background: Stent graft infection is a rare but seri-
ous complication in patients who underwent endovascu-
lar aortic aneurysm repair. Particularly removal of su-
prarenal fixing stent graft carries risk of aortic or renal
artery injury. There have been reported several options
of aortic reconstruction after successful removal of in-
fected device.
Technical Description: 1. Exposure of aorta and prox-
imal and distal control. 2. Removal of aortic stent graft with
syringe technique which include preparation of syringe,
exposure of stent graft, removal of stent graft. 3. Prepara-
tion of cyropreserved aortic and arterial allografts: thawing
and rinsing of cryopreserved arterial allografts, composition
of allografts to make bifurcated aortic graft. 4. In situ aortic
reconsctruction: aorto-iliac reconstruction and graft omen-
tum wrapping of the grafts.
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Objectives: To compare outcomes of mesenteric an-
gioplasty and stenting (PTAS) using iCAST covered stents
(C-PTAS; Atrium, Hudson, NH) ) or bare metal stents
(BM-PTAS) in patients with chronic mesenteric ischemia
(CMI).
Methods:We reviewed the clinical data of 225 patients
(65 male and 160 female; mean age 7212 yrs) treated for
CMI (2000-2010). Outcomes were analyzed in patients
who had primary intervention or re-intervention using
BM-PTAS (n164 patients/ 197 vessels) or C-PTAS
(n61 patients/ 67 vessels). End-points were freedom
from restenosis, recurrence and re-intervention, and pri-
mary and secondary patency rates.
Results: Patients in both groups had similar demo-
graphics, cardiovascular risk factors and extent of disease.
Mean follow up was 2712 months. Patients treated by
C-PTS had less restenosis, recurrences and re-interventions
compared to those treated by BM-PTAS, both in the
primary intervention and in the re-intervention groups
(P.05); primary patency at 2-years was significantly
higher for C-PTAS compared to BM-PTAS in the primary
intervention group (916 vs 605; P.003).
Conclusions: In this non-randomized study covered
stents were associated with less restenosis, recurrences and
re-interventions in patients undergoing primary interven-
tions or re-interventions for CMI.
Table.
Bare metal stents
(n164 pts/197 vessels)
Covered stents (n61
pts/ 67 vessels) P
value%  SDa
Primary
intervention
group
n149 pts/181 vessels n42 pts/45 vessels
Freedom from
restenosis
534 926 .003
Freedom from
recurrence
584 955 .001
Freedom from
re-intervention
595 955 .001
Primary patency 605 916 .003
Secondary patency 952 100 .46
Reintervention
group
n15 pts/16 vessels 21 pts/22 vessels
Freedom from
restenosis
4914 8910 .04
Freedom from
recurrence
4414 8910 .001
Freedom from
re-intervention
5612 8910 .03
Primary patency 4514 6012 .08
Secondary patency 100 8210 .10
a2-year Kaplan-Meier estimates
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Progress in Management of Visceral Ischemia from
Type B Dissections
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Objectives: Malperfusion syndrome is a known predic-
tor of poor outcome in acute type B dissection.We describe
our experience with endovascular revascularization in the
acute setting.
Methods: Consecutive patients undergoing interven-
tion for malperfusion or branch vessel ischemia presenting
with acute type B dissection between 6/2003 and 3/2011
were reviewed. Details of the presenting condition, surgical
intervention, and postoperative course were collected. De-
scriptive and inferential statistical analyses were planned
including survival and freedom from reintervention analysis
using a Cox proportional hazards model.
Results: A total of 61 patients were identified with
malperfusion in at least one territory, including spinal cord
in 7/61 (12%) mesenteric in 37/61 (61%), renal in 45/61
(73%) and lower extremity in 38/61 (62%). Thoracic stent
grafts were placed in all patients, and 41% of patients
required adjunctive branch vessel stenting. After interven-
tion, resolution of the ischemia was reported in 57/61
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